SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 70 filers reported holding SPERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20,760 | -13.5% | 12,000 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $24,000 | -22.6% | 12,000 | -71.4% | 0.01% | -20.0% |
| Q2 2022 | $31,000 | -91.5% | 42,000 | 0.0% | 0.01% | -91.9% |
| Q1 2022 | $365,000 | -24.6% | 42,000 | +39.1% | 0.12% | -18.4% |
| Q4 2021 | $484,000 | +30.1% | 30,200 | +49.5% | 0.15% | +19.7% |
| Q3 2021 | $372,000 | -12.5% | 20,200 | -23.5% | 0.13% | -18.6% |
| Q1 2021 | $425,000 | -7.2% | 26,410 | +11.8% | 0.16% | -7.1% |
| Q4 2020 | $458,000 | – | 23,615 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
| Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
| VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
| AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
| Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
| BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
| Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
| Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
| Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
| Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |